Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-24

FDA Approved: MESALAMINE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for mesalamine submitted by ANI Pharmaceuticals, Inc. This action supplements the existing approval for mesalamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)